WMT · News · 20260908N
Opioid Settlement
Walmart Inc. · 2026-09-08 · Importance 40 · Surprise 42 · In source text
Walmart settled a U.S. government opioid case for $50 million on September 8, 2026, substantially below the multibillion-dollar amount initially sought. Walmart did not admit liability, and the settlement resolves the reported case while requiring enhanced pharmacy oversight. The resolution follows Walmart’s earlier $3.1 billion opioid settlement and highlights continuing pharmacy-compliance obligations.
Key facts
- Walmart settled a potential multibillion-dollar opioid case with the US government for $50 million. source
- Walmart did not admit liability in the $50 million opioid settlement, which the company said removes legal uncertainty and is immaterial financially. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | committed | -0.0% | Walmart settled a potential multibillion-dollar opioid case with the US government for $50 million. |